DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
E.e.s. 200 is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in E.E.S. 200 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
A generic version of E.E.S. 200 was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Arbor Pharms Llc||E.E.S. 200||erythromycin ethylsuccinate||SUSPENSION;ORAL||061639-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|